Article

LASIK platforms perform well with minor differences

New Orleans—Separate prospective comparison studies of LASIK platforms have shown that the systems evaluated produced similarly successful outcomes with relatively minor differences. According to speakers at a refractive surgery session at the American Academy of Ophthalmology meeting, these studies also represent a welcome trend toward head-to-head comparisons of the various platforms and a step toward expanding evaluation criteria.

In the first study presented, a randomized, prospective, masked comparison of four excimer laser systems used in conventional LASIK, investigators found that all performed well with subtle differences in contrast acuity and refractive stability, said Steven C. Schallhorn, MD, director of cornea and refractive surgery, Naval Medical Center, San Diego.

However, there were differences in stability, contrast acuity, treatment diameter, ablation depth, and ergonomics, he added.

A nomogram adjustment group of 20 patients treated with each laser was evaluated at 1 month to determine whether the nomograms provided by the laser companies required adjustment. No adjustments were necessary, and these patients were included in the data analyzed for the study, Dr. Schallhorn said.

Subsequently, 400 additional patients were treated, 100 with each laser.

Dr. Schallhorn reported that a "glitch" occurred at this point in the study.

"Following completion of the treatments, an error was discovered. A minor, routine software upgrade altered the routine nomogram. One primary cohort had undercorrection by 8%. All laser companies were told of the situation but not which laser was involved. They all agreed to a redo of the primary cohort for the affected laser," he explained.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
© 2025 MJH Life Sciences

All rights reserved.